Company / Revenue
Medpace Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$2.5B
FY2025
5-year range
$925.9M / $2.5B
FY2021-FY2025
Trend
+20.0%
vs FY2024
Sector context
#72 of 156
Health Care
What the data says
At $2.5B, Medpace's revenue ranks #72 of 156 in the Health Care sector. Revenue has increased for 3 consecutive years, from $926M in FY2022 to $2.5B in FY2025.
Based on SEC 10-K filings.
$2.5B in FY2025 with a 5-year CAGR of +22.3%.
Improved from $1.9B to $2.5B over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +39.8%
- 5-Year CAGR
- +22.3%
- 10-Year CAGR
- -
Sector benchmark
#72 of 156 in Health CareTop 46% of 156This company $2.5B Sector average $19.0B
▼
-86.7% below sector average
Key checks
Key Insights
- Medpace's revenue has grown for 3 consecutive years.
- 5-year CAGR of +22.3%, indicating consistent growth.
- In FY2025, revenue increased 20.0% year-over-year.
- Ranks #72 out of 156 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
- Strong return on equity: 147.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.5B | +20.0% |
| FY2024 | $2.1B | +11.8% |
| FY2023 | $1.9B | +103.7% |
| FY2022 | $925.9M | -18.9% |
| FY2021 | $1.1B | +23.4% |
| FY2020 | $925.9M | +7.5% |
| FY2019 | $861.0M | +104.2% |
| FY2018 | $421.6M | -3.3% |
| FY2017 | $436.2M | +3.5% |
| FY2016 | $421.6M | +17.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026